Druggability & Clinical Context
Druggability
Low
Score: 0.40
Target Class
Signaling Protein
Druggability Analysis
Structural Tractability0.30
Key Metrics
PDB Structures:
0
Known Drugs:
0
Approved:
0
In Clinical Trials:
0
Therapeutic Areas:neurodegeneration
Mechanism: Prioritized from 1 SciDEX hypotheses, including: Microglia-Derived Extracellular Vesicle Engineering for Targeted Mitochondrial Delivery
Known Drugs:No known drugs targeting this protein